Home >> Chemicals Listing >> hot product list by 1

11-phenyloctahydro-1H-8a,4a-(epithiomethenoazeno)benzo[b]cyclopenta[e][1,4]oxathiine (7241-78-3)

Identification
Name:	11-phenyloctahydro-1H-8a,4a-(epithiomethenoazeno)benzo[b]cyclopenta[e][1,4]oxathiine
CAS:	7241-78-3
Molecular Formula:	C₁₈H₂₁NOS₂
Molecular Weight:	331.4954
InChI:	InChI=1/C18H21NOS2/c1-2-7-13(8-3-1)16-19-17-11-4-5-12-18(17,22-16)21-15-10-6-9-14(15)20-17/h1-3,7-8,14-15H,4-6,9-12H2
Molecular Structure:
Properties
Flash Point:	268.8°C
Boiling Point:	520.8°C at 760 mmHg
Density:	1.43g/cm³
Refractive index:	1.748
Flash Point:	268.8°C
Safety Data

Other Product

3a,11a,14-trihydroxy-11-methoxy-9,13a,15a-trimethyl-1-(5-oxo-2,5-dihydrofuran-3-yl)-2,3,3a,4a,5,6a,9,10,11,11a,12a,13,13a,13b,14,15a-hexadecahydro-7aH-cyclopenta[7,8]oxireno[8a,9]phenanthro[2,3-b]pyrano[3,2-e][1,4]dioxin-15(1H)-one
Spiro[benzo[b]cyclopenta[e][1,4]diazepine-10(1H),1'-cyclopentane],2,3,9,10a-tetrahydro-9-[(4-phenyl-1-piperazinyl)methyl]-
Benzoic acid,4-[[2-(2,3,9,10a-tetrahydrospiro[benzo[b]cyclopenta[e][1,4]diazepine-10(1H),1'-cyclopentan]-9-yl)ethyl]amino]-
Spiro[benzo[b]cyclopenta[e][1,4]diazepine-10(1H),1'-cyclopentane],2,3,9,10a-tetrahydro-9-[2-(4-morpholinyl)ethyl]-
Spiro(benzo(b)cyclopenta(e)(1,4)diazepine-10(1H),1-cyclopentane), 2,3,9,10a-tetrahydro-9-(3-(4-morpholinyl)propyl)-
trans-4-Methyl-8a-phenyloctahydro-2H-1,4-benzoxazine
(4aS,6S,8aR,8bR,10aR,11R,13aR,13bS)-6-(Acetyloxy)-5,6,7,8,8a,8b,10,10a,11,12,13,13a-dodecahydro-8a,10a-diMethyl-2-phenyl-11-[(1R,2E,4R)-1,4,5-triMethyl-2-hexen-1-yl]-4a,13b-etheno-1H,9H-benzo[c]cyclopenta[h][1,2,4]triazolo[1,2-a]cinnoline-1,3(2H)-dione
4-piperidin-1-yl-4,5-dihydro-3H-thiochromeno[3,4-e]oxathiine 2,2-dioxide
Spiro[benzo[b]cyclopenta[e][1,4]diazepine-10(1H),1'-cyclopentane],2,3,9,10a-tetrahydro-9-[3-(1-piperidinyl)propyl]-
Spiro[benzo[b]cyclopenta[e][1,4]diazepine-10(1H),1'-cyclopentane],2,3,9,10a-tetrahydro-9-[3-(1-pyrrolidinyl)propyl]-
Spiro(benzo(b)cyclopenta(e)(1,4)diazepine-10(1H),1-cyclopentane), 2,3,9,10a-tetrahydro-9-(2-(1-pyrrolidinyl)ethyl)-
Spiro(benzo(b)cyclopenta(e)(1,4)diazepine-10(1H),1-cyclopentane), 2,3,9,10a-tetrahydro-9-(3-(2-methyl-1-piperidinyl)propyl)-
Spiro(benzo(b)cyclopenta(e)(1,4)diazepine-10(1H),1-cyclopentane), 2,3,9,10a-tetrahydro-9-(2-(2-methyl-1-piperidinyl)ethyl)-
Spiro(benzo(b)cyclopenta(e)(1,4)diazepine-10(1H),1-cyclopentane), 2,3,9,10a-tetrahydro-9-(2-(1-piperidinyl)ethyl)-
Benzo[4,5]cyclodeca[1,2-b]furan-2(1H)-one,8,- 11,13-tris(acetyloxy)-4-chloro-3a,4,5,8,8a,11,- 12,12a,13,13a-decahydro-12,13a-dihydroxy-1,- 8a,12-trimethyl-5-methylene-,(1R,3aR,4S,- 6Z,8S,8aS,11R,12S,12aS,13S,13aR)-
Benzoic acid,2-[[2-(2,3,9,10a-tetrahydrospiro[benzo[b]cyclopenta[e][1,4]diazepine-10(1H),1'-cyclopentan]-9-yl)ethyl]amino]-
[4aS-[4aα,6α,8aα,8bβ,10aα,11α(1S*,2E,4R*),13aβ,13bα]]-5,6,7,8,8a,8b,10,10a,11,12,13,13a-Dodecahydro-6-hydroxy-8a,10a-diMethyl-2-phenyl-11-[1,4,5-triMethyl-5-[(tetrahydro-2H-pyran-2-yl)oxy]-2-hexenyl]-4a,13b-etheno-1H,9H-benzo[c]cyclopenta[h][1,2,4]triazolo[1,2-a]cinnoline-1,3(2H)-dione
[4aS-[4aα,6α,8aα,8bβ,10aα,11α(1S*,2E,4R*),13aβ,13bα]]-6-(Acetyloxy)-5,6,7,8,8a,8b,10,10a,11,12,13,13a-dodecahydro-11-[2-hydroxy-1,4,5-triMethyl-3-(phenylsulfonyl)-5-[(tetrahydro-2H-pyran-2-yl)oxy]hexyl]-8a,10a-diMethyl-2-phenyl-4a,13b-etheno-1H,9H-benzo[c]cyclopenta[h][1,2,4]triazolo[1,2-a]cinnoline-1,3(2H)-dione
3'H-Cyclopenta[3,4]-18-norandrost-3-ene-3',9,13-tricarboxylicacid, tetrahydro-4'-hydroxy-4,5',5'-trimethyl-15-(1-methylethenyl)-, 13-b-D-glucopyranosyl ester, (3b,3'b,4a,4'a,5b,8a,9b,10a,13a,14b,15b)- (9CI)
Spiro[benzo[b]cyclopenta[e][1,4]diazepine-10(9H),1'-cyclopentane]-9-ethanamine,1,2,3,10a-tetrahydro-N-(4-nitrophenyl)-